Last 7 days
-1.9%
Last 30 days
-4.4%
Last 90 days
-14.9%
Trailing 12 Months
-11.7%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 396.9B | 94.9B | -4.42% | -11.67% | 22.12 | 4.18 | 1.25% | -14.07% |
LLY | 298.8B | 28.5B | 1.30% | 17.85% | 47.85 | 10.47 | 0.79% | 11.88% |
MRK | 272.8B | 59.3B | -5.09% | 32.83% | 17.88 | 4.63 | 21.72% | 11.27% |
PFE | 226.2B | 100.3B | -5.50% | -20.78% | 7.21 | 2.25 | 23.43% | 42.74% |
BMY | 142.4B | 46.2B | -5.97% | -4.10% | 22.5 | 3.08 | -0.49% | -9.54% |
MID-CAP | ||||||||
PRGO | 4.5B | 4.5B | -8.55% | -11.11% | -32.05 | 1.01 | 7.56% | -104.06% |
RETA | 3.2B | 2.2M | 109.33% | 133.59% | -10.15 | 1.4K | -80.71% | -4.88% |
SMALL-CAP | ||||||||
SUPN | 1.9B | 667.2M | -10.48% | 10.28% | 30.48 | 2.77 | 15.09% | 13.64% |
TLRY | 1.6B | 602.5M | -5.76% | -54.20% | -2.78 | 2.67 | 18.18% | -18.59% |
CGC | 923.6M | 478.9M | -20.83% | -73.20% | -0.29 | 1.93 | -31.50% | -634.70% |
INVA | 772.8M | 285.2M | -9.04% | -42.36% | 3.51 | 2.71 | -27.21% | -40.28% |
CRON | 726.9M | 114.5M | -12.79% | -47.96% | -4.31 | 6.35 | 27.90% | 57.40% |
ACRS | 539.5M | 29.8M | -36.94% | -53.16% | -6.21 | 18.13 | 340.05% | 4.35% |
OCUL | 379.1M | 51.5M | -14.46% | -5.94% | -5.34 | 7.36 | 18.32% | -984.05% |
ENDP | 94.1M | 2.3B | -43.99% | -88.43% | -0.03 | 0.04 | -22.53% | -376.66% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -1.1% | 94,943 | 96,041 | 95,588 | 94,880 | 93,775 |
Gross Profit | -1.4% | 63,854 | 64,762 | 64,866 | 64,490 | 63,920 |
S&GA Expenses | -2.5% | 24,765 | 25,407 | 25,318 | 25,165 | 24,659 |
EBITDA | -2.0% | 28,971 | 29,560 | 27,685 | 28,604 | - |
EBITDA Margin | -0.9% | 0.31* | 0.31* | 0.29* | 0.30* | - |
Earnings Before Taxes | -2.8% | 21,725 | 22,360 | 20,387 | 21,209 | 22,776 |
EBT Margin | -1.7% | 0.23* | 0.23* | 0.21* | 0.22* | - |
Interest Expenses | 73.6% | 276 | 159 | 128 | 130 | 183 |
Net Income | -6.3% | 17,941 | 19,157 | 18,366 | 19,830 | 20,878 |
Net Income Margin | -5.3% | 0.19* | 0.20* | 0.19* | 0.21* | - |
Free Cahsflow | -3.1% | 17,185 | 17,739 | 19,950 | 19,733 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 7.0% | 187,378 | 175,124 | 177,724 | 178,355 | 182,018 |
Current Assets | -15.2% | 55,294 | 65,236 | 63,847 | 60,424 | 60,979 |
Cash Equivalents | 24.4% | 14,127 | 11,355 | 10,983 | 10,463 | 14,487 |
Inventory | 6.9% | 12,483 | 11,675 | 11,437 | 10,990 | 10,387 |
Net PPE | 9.1% | 19,803 | 18,152 | 18,354 | 18,701 | 18,962 |
Goodwill | 35.5% | 45,231 | 33,383 | 34,166 | 34,935 | 35,246 |
Liabilities | 10.0% | 110,574 | 100,525 | 101,367 | 103,646 | 107,995 |
Current Liabilities | 22.5% | 55,802 | 45,543 | 44,821 | 43,390 | 45,226 |
. Short Term Borrowings | 188.7% | 12,771 | 4,424 | 4,305 | 4,297 | 3,766 |
Long Term Debt | - | 32,116 | - | - | - | - |
LT Debt, Current | - | 2,131 | - | - | - | - |
LT Debt, Non Current | -2.6% | 26,888 | 27,603 | 28,292 | 28,851 | 29,985 |
Shareholder's Equity | 3.0% | 76,804 | 74,599 | 76,357 | 74,709 | 74,023 |
Retained Earnings | 0.3% | 128,345 | 127,917 | 126,216 | 124,380 | 123,060 |
Accumulated Depreciation | -0.9% | 28,529 | 28,790 | 29,001 | 28,717 | - |
Shares Outstanding | -0.1% | 2,628 | 2,630 | 2,629 | - | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -1.8% | 21,194 | 21,576 | 23,582 | 23,315 | 23,410 |
Share Based Compensation | -0.2% | 1,138 | 1,140 | 1,118 | 1,106 | 1,135 |
Cashflow From Investing | 7.2% | -12,371 | -13,334 | -14,352 | -12,132 | -8,683 |
Cashflow From Financing | 36.7% | -8,871 | -14,007 | -12,289 | -13,307 | -14,047 |
Buy Backs | 5.7% | 6,035 | 5,711 | 3,937 | 3,595 | 3,456 |
17.7%
0%
0%
Y-axis is the maximum loss one would have experienced if Johnson & Johnson was unfortunately bought at previous high price.
9.5%
7.6%
6.5%
13.4%
FIve years rolling returns for Johnson & Johnson.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | added | 3.92 | 3,092,040 | 29,398,000 | 0.82% |
2023-03-14 | AWM CAPITAL, LLC | added | 4.65 | 19,854 | 492,854 | 0.17% |
2023-03-13 | Claro Advisors LLC | added | 11.7 | 325,670 | 3,244,670 | 1.06% |
2023-03-10 | BAILLIE GIFFORD & CO | added | 9.09 | 3,078 | 19,078 | -% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -3.08 | 23,020,400 | 502,397,000 | 0.55% |
2023-03-10 | MATHER GROUP, LLC. | added | 4.4 | 543,679 | 4,761,680 | 0.09% |
2023-03-08 | SHEETS SMITH WEALTH MANAGEMENT | added | 0.04 | 178,338 | 2,361,340 | 0.37% |
2023-03-08 | Capital Asset Advisory Services LLC | added | 3.73 | 413,385 | 3,381,380 | 0.27% |
2023-03-07 | Great Lakes Retirement, Inc. | new | - | 1,239,020 | 1,239,020 | 0.32% |
2023-03-07 | Nordwand Advisors, LLC | new | - | 188,939,000 | 188,939,000 | 23.56% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 9.44% | 246,826,621 | SC 13G/A | |
Jan 31, 2023 | blackrock inc. | 7.6% | 198,802,769 | SC 13G/A | |
Feb 14, 2022 | state street corp | 5.51% | 144,996,127 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 8.92% | 234,782,632 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 7.6% | 200,021,352 | SC 13G/A | |
Feb 12, 2021 | state street corp | 5.47% | 144,029,634 | SC 13G | |
Feb 10, 2021 | vanguard group inc | 8.66% | 227,946,104 | SC 13G/A | |
Jan 29, 2021 | blackrock inc. | 7.2% | 188,510,542 | SC 13G/A | |
Feb 13, 2020 | state street corp | 5.77% | 151,867,233 | SC 13G | |
Feb 12, 2020 | vanguard group inc | 8.67% | 228,297,775 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | - - | - - | - - | - - |
Current Inflation | 71.21 -52.85% | 93.65 -37.99% | 134.05 -11.24% | 169.21 12.04% | 199.06 31.81% |
Very High Inflation | - - | - - | - - | - - | - - |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 22, 2023 | PX14A6G | PX14A6G | |
Mar 16, 2023 | ARS | ARS | |
Mar 15, 2023 | DEF 14A | DEF 14A | |
Mar 15, 2023 | DEFA14A | DEFA14A | |
Mar 15, 2023 | DEFA14A | DEFA14A | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 09, 2023 | 4 | Insider Trading | |
Mar 08, 2023 | 4 | Insider Trading | |
Feb 22, 2023 | 3 | Insider Trading | |
Feb 16, 2023 | 10-K | Annual Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-06 | Swanson James D. | sold | -164,199 | 154 | -1,061 | see remarks |
2023-02-13 | Wengel Kathryn E | acquired | - | - | 10,839 | evp, chief to and risk officer |
2023-02-13 | Mongon Thibaut | acquired | - | - | 13,710 | exec vp, ww chair, cons health |
2023-02-13 | Duato Joaquin | sold (taxes) | -2,203,170 | 162 | -13,599 | ceo and chairman of the board |
2023-02-13 | Fasolo Peter | acquired | - | - | 12,468 | exec vp, chief hr officer |
2023-02-13 | Hait William | acquired | - | - | 9,640 | see remarks |
2023-02-13 | Hait William | sold (taxes) | -742,978 | 162 | -4,586 | see remarks |
2023-02-13 | Forminard Elizabeth | acquired | - | - | 2,555 | executive vp, general counsel |
2023-02-13 | Wolk Joseph J | sold (taxes) | -1,389,720 | 162 | -8,578 | exec vp, cfo |
2023-02-13 | Broadhurst Vanessa | acquired | - | - | 3,981 | evp, global corp affairs |
Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Jan. 01, 2023 | Jan. 02, 2022 | Jan. 03, 2021 | |
Income Statement [Abstract] | |||
Sales to customers | $ 94,943 | $ 93,775 | $ 82,584 |
Cost of products sold | 31,089 | 29,855 | 28,427 |
Gross profit | 63,854 | 63,920 | 54,157 |
Selling, marketing and administrative expenses | 24,765 | 24,659 | 22,084 |
Research and development expense | 14,603 | 14,714 | 12,159 |
In-process research and development (Note 5) | 783 | 900 | 181 |
Interest income | (490) | (53) | (111) |
Interest expense, net of portion capitalized (Note 4) | 276 | 183 | 201 |
Other (income) expense, net | 1,871 | 489 | 2,899 |
Restructuring (Note 20) | 321 | 252 | 247 |
Earnings before provision for taxes on income | 21,725 | 22,776 | 16,497 |
Provision for taxes on income (Note 8) | 3,784 | 1,898 | 1,783 |
Net earnings | $ 17,941 | $ 20,878 | $ 14,714 |
Net earnings per share (Notes 1 and 15) | |||
Basic (in dollars per share) | $ 6.83 | $ 7.93 | $ 5.59 |
Diluted (in dollars per share) | $ 6.73 | $ 7.81 | $ 5.51 |
Average shares outstanding (Notes 1 and 15) | |||
Basic (in shares) | 2,625.2 | 2,632.1 | 2,632.8 |
Diluted (in shares) | 2,663.9 | 2,674.0 | 2,670.7 |
Consolidated Balance Sheets - USD ($) $ in Millions | Jan. 01, 2023 | Jan. 02, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents (Notes 1 and 2) | $ 14,127 | $ 14,487 |
Marketable securities (Notes 1 and 2) | 9,392 | 17,121 |
Accounts receivable trade, less allowances for doubtful accounts $203 (2021, $230) | 16,160 | 15,283 |
Inventories (Notes 1 and 3) | 12,483 | 10,387 |
Prepaid expenses and other receivables | 3,132 | 3,701 |
Total current assets | 55,294 | 60,979 |
Property, plant and equipment, net (Notes 1 and 4) | 19,803 | 18,962 |
Intangible assets, net (Notes 1 and 5) | 48,325 | 46,392 |
Goodwill (Notes 1 and 5) | 45,231 | 35,246 |
Deferred taxes on income (Note 8) | 9,123 | 10,223 |
Other assets | 9,602 | 10,216 |
Total assets | 187,378 | 182,018 |
Current liabilities | ||
Loans and notes payable (Note 7) | 12,771 | 3,766 |
Accounts payable | 11,703 | 11,055 |
Accrued liabilities | 11,456 | 13,612 |
Accrued rebates, returns and promotions | 14,417 | 12,095 |
Accrued compensation and employee related obligations | 3,328 | 3,586 |
Accrued taxes on income (Note 8) | 2,127 | 1,112 |
Total current liabilities | 55,802 | 45,226 |
Long-term debt (Note 7) | 26,888 | 29,985 |
Deferred taxes on income (Note 8) | 6,374 | 7,487 |
Employee related obligations (Notes 9 and 10) | 6,767 | 8,898 |
Long-term taxes payable (Note 1) | 4,306 | 5,713 |
Other liabilities | 10,437 | 10,686 |
Total liabilities | 110,574 | 107,995 |
Commitments and Contingencies (Note 19) | ||
Shareholders’ equity | ||
Preferred stock — without par value (authorized and unissued 2,000,000 shares) | 0 | 0 |
Common stock — par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) | 3,120 | 3,120 |
Accumulated other comprehensive income (loss) (Note 13) | (12,967) | (13,058) |
Retained earnings | 128,345 | 123,060 |
Stockholders' Equity before Treasury Stock | 118,498 | 113,122 |
Less: common stock held in treasury, at cost (Note 12) (506,246,000 shares and 490,878,000 shares) | 41,694 | 39,099 |
Total shareholders’ equity | 76,804 | 74,023 |
Total liabilities and shareholders’ equity | $ 187,378 | $ 182,018 |